Filing Flows › Acadia Pharmaceuticals (ACAD) › Free cash flow
Acadia Pharmaceuticals (ACAD) free cash flow by quarter
Acadia Pharmaceuticals' free cash flow was $10.3M in Q3 2026 (third quarter 2026), -89% from Q2 2026. Over the last 5 quarters it ranged from $10.3M (Q3 2026) to $95.7M (Q2 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $10.3M | -89% | -86% |
| Q2 2026 | $95.7M | +233% | +50% |
| Q1 2026 | $28.8M | -61% | — |
| Q3 2025 | $73.9M | +16% | — |
| Q2 2025 | $63.7M | — | — |
Q3 2026 at a glance
Acadia Pharmaceuticals, Q3 2026: revenue $342M (+23% year over year), operating margin 21.0%, net earnings $53.5M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Acadia Pharmaceuticals' free cash flow?
Acadia Pharmaceuticals' free cash flow was $10.3M in Q3 2026 (third quarter 2026), -89% from Q2 2026.
How has Acadia Pharmaceuticals' free cash flow changed?
Over the last 5 quarters it ranged from $10.3M (Q3 2026) to $95.7M (Q2 2026).
Q3 2026 results → · How Acadia Pharmaceuticals makes money →